Clinical Trials in Tai’an, China
Locations / Tai’an, China
Delta Trials records 126 clinical trials conducted in Tai’an, China, making it a notable site of clinical research activity. These trials across 169 distinct therapeutic areas, reflecting the scope and diversity of clinical research in this location. Since 2020, 8 trials in this location were terminated, reflecting shifts in research priorities or feasibility. Delta Trials updates this record as new data becomes available from ClinicalTrials.gov, providing a versioned view of how research activity in Tai’an has changed over time.
126
Total Trials
169
Conditions
8
Terminated since 2020
Browse by condition (169 total)
- Ulcerative colitis 8 trialsAll Ulcerative colitis trials
- Acute ischemic stroke 6 trialsAll Acute ischemic stroke trials
- Non-small cell lung cancer 6 trialsAll Non-small cell lung cancer trials
- Esophageal neoplasms 3 trialsAll Esophageal neoplasms trials
- Atrial fibrillation 3 trialsAll Atrial fibrillation trials
- Chronic kidney disease 3 trialsAll Chronic kidney disease trials
- Coronary artery disease 2 trialsAll Coronary artery disease trials
- Thrombosis 2 trialsAll Thrombosis trials
- Ischemic stroke 2 trialsAll Ischemic stroke trials
- Type 2 diabetes mellitus 2 trialsAll Type 2 diabetes mellitus trials
- Chronic hepatitis b 2 trialsAll Chronic hepatitis b trials
- Familial alzheimer disease (fad) 2 trialsAll Familial alzheimer disease (fad) trials
- Acute coronary syndrome 2 trialsAll Acute coronary syndrome trials
- Heart failure 2 trialsAll Heart failure trials
- Small lymphocytic lymphoma 2 trialsAll Small lymphocytic lymphoma trials
- Chronic lymphocytic leukemia 2 trialsAll Chronic lymphocytic leukemia trials
- Advanced solid tumor 2 trialsAll Advanced solid tumor trials
- Colitis, ulcerative 2 trialsAll Colitis, ulcerative trials
- Cardiovascular disease 2 trialsAll Cardiovascular disease trials
- Her2-positive breast cancer 2 trialsAll Her2-positive breast cancer trials